On January 5, Langmook Healthcare announced the completion of Series A financing of nearly 100 million yuan. This round of financing was jointly led by Guangzhou Industrial Investment and Yueke Finance, followed by Hongde Investment, Development Zone Fund, Wanlian Jianzhi, and Guoju Venture Capital. Xiqiao Capital acted as financial advisor for this round of financing. The funds raised will mainly be used for clinical follow-up and registration of core products, construction of industrial production bases, marketing team construction, and R&D expansion of subsequent product pipelines.

On January 5, Langmook Healthcare announced the completion of Series A financing of nearly 100 million yuan. This round of financing was jointly led by Guangzhou Industrial Investment and Yueke Finance, followed by Hongde Investment, Development Zone Fund, Wanlian Jianzhi, and Guoju Venture Capital. Xiqiao Capital acted as financial advisor for this round of financing. The funds raised will mainly be used for clinical follow-up and registration of core products, construction of industrial production bases, marketing team construction, and R&D expansion of subsequent product pipelines.